Sleep Effects of Naproxen, Benzonatate, Levocetirizine, Metformin, Montelukast (Singulair), and Tadalafil
Direct Answer
Among these medications, levocetirizine is the most likely to cause sleep disturbances—specifically increased daytime sleepiness and paradoxically improved nocturnal sleep quality—while the others have minimal to no clinically significant impact on sleep architecture or quality. 1
Medication-by-Medication Sleep Impact Analysis
Levocetirizine (Antihistamine)
Levocetirizine causes measurable sleep-related effects that patients should anticipate:
- Daytime sleepiness is the primary adverse effect, occurring more frequently than with desloratadine or rupatadine in head-to-head trials 1
- Improved nocturnal sleep quality and reduced sleep latency are documented benefits, meaning patients fall asleep faster and sleep more deeply 1
- Dream anxiety is reduced compared to first-generation antihistamines 1
- Unlike cetirizine and hydroxyzine, levocetirizine does not negatively affect mood states (depression/anxiety scores) 1
Clinical implication: If your patient complains of excessive daytime drowsiness, levocetirizine is the likely culprit. Consider switching to a non-sedating alternative like desloratadine, or dose at bedtime to leverage the sedative effect beneficially.
Naproxen (NSAID)
Naproxen has no documented sleep-disrupting properties in FDA labeling or clinical literature:
- The FDA label lists common CNS effects (headache, dizziness, drowsiness, lightheadedness) but does not identify insomnia or sleep disturbance as adverse reactions 2
- In a combination study with diphenhydramine for dental pain, naproxen 440 mg alone showed no sleep benefit or detriment—all sleep improvements were attributable to diphenhydramine 3
- Rare CNS effects (<1% incidence) include "insomnia" and "dream abnormalities," but these are not clinically significant at therapeutic doses 2
Clinical implication: Naproxen is sleep-neutral. If a patient on naproxen reports insomnia, investigate other causes (pain itself, concurrent medications, caffeine).
Benzonatate (Antitussive)
No evidence exists linking benzonatate to sleep disturbances:
- Benzonatate is a peripherally acting cough suppressant with no CNS depressant activity and no documented impact on sleep architecture 4
- It does not appear in systematic reviews of medication-induced sleep disturbances 4
Clinical implication: Benzonatate is sleep-neutral and safe to use in patients with insomnia.
Metformin (Antidiabetic)
Metformin does not interfere with sleep and may offer limited benefit:
- A 2025 Mayo Clinic review concluded metformin "does not appear to interfere with sleep, with some studies suggesting a limited benefit" 5
- The FDA label warns of "unusual somnolence" as a symptom of lactic acidosis (a medical emergency), not a routine side effect 6
- Metformin's GI side effects (nausea, diarrhea) occur early in treatment but do not persist to disrupt sleep long-term 6
Clinical implication: Metformin is sleep-neutral. If a patient on metformin reports severe somnolence, rule out lactic acidosis immediately (check lactate, renal function, pH).
Montelukast/Singulair (Leukotriene Receptor Antagonist)
Montelukast has no documented sleep-disrupting effects in the provided evidence:
- It does not appear in systematic reviews of medications causing insomnia, sedation, or parasomnias 4
- The FDA has issued warnings about neuropsychiatric effects (agitation, depression, suicidal ideation), but sleep disturbance is not a primary concern
Clinical implication: Montelukast is sleep-neutral. Monitor for mood/behavioral changes, not insomnia.
Tadalafil (PDE-5 Inhibitor)
Tadalafil may worsen obstructive sleep apnea (OSA) but does not cause primary insomnia:
- A 2025 review notes that PDE-5 inhibitors like sildenafil "may exacerbate severe obstructive sleep apnea, warranting caution" 5
- Tadalafil's mechanism (vasodilation via nitric oxide-cGMP pathway) can theoretically worsen upper airway collapsibility during sleep 7
- However, tadalafil does not cause insomnia, nightmares, or daytime sleepiness in patients without OSA 7
Clinical implication: Screen patients on tadalafil for OSA symptoms (snoring, witnessed apneas, morning headaches, daytime fatigue). If OSA is present or suspected, refer for polysomnography before continuing tadalafil 8. In patients without OSA, tadalafil is sleep-neutral.
Summary Algorithm: Which Medication to Blame for Sleep Issues?
If your patient reports:
Daytime sleepiness → Levocetirizine is the most likely cause 1. Consider switching to desloratadine or dosing at bedtime.
Insomnia/difficulty falling asleep → None of these medications are primary culprits. Investigate other causes (pain, caffeine, stress, undiagnosed sleep disorder).
Excessive fatigue with confusion/hyperventilation → Metformin-induced lactic acidosis (medical emergency) 6. Check lactate, renal function, and pH immediately.
Snoring/apneas/morning headaches → Tadalafil may be worsening OSA 5. Refer for sleep study.
Improved sleep quality → Levocetirizine may be providing a beneficial sedative effect 1.
Common Pitfalls to Avoid
Do not assume all antihistamines are equally sedating: Levocetirizine causes more daytime sleepiness than desloratadine or rupatadine 1. First-generation antihistamines (diphenhydramine, hydroxyzine) are far worse and should be avoided in chronic use 1.
Do not overlook OSA in patients on tadalafil: PDE-5 inhibitors can unmask or worsen sleep apnea 5. A patient complaining of "poor sleep" on tadalafil may need polysomnography, not a sleep aid.
Do not attribute metformin's GI side effects to "sleep disruption": Early nausea/diarrhea resolves within weeks and does not chronically impair sleep 6, 5.
Do not stop naproxen for "insomnia" without evidence: Naproxen is sleep-neutral 2, 3. If a patient on naproxen has insomnia, the cause is elsewhere (uncontrolled pain, anxiety, caffeine).